Stem Pharm, Inc

stempharm.com

Stem Pharm offers unique biomaterials for cell and tissue manufacturing. Applications include medical devices for drug discovery, cell therapy, and regenerative medicine. Stem Pharm's synthetic biomaterials support the optimization of cell expansion and differentiation, human tissue formation and cell/tissue delivery applications. Through control of the biomaterial properties (e.g. mechanical stiffness, cell adhesion, degradability), and utilizing chemistries that maintain cellular health and function, we provide cell-specific biomaterials to researchers and clinicians to fill unmet needs in their workflows. Currently, cell and tissue manufacturing processes often rely on animal-derived biomaterials that are complex and variable in nature and problematic for human in vivo applications due to potential pathogen transmission or an immunogenic response. Our materials are synthetic, defined, and optimized to produce functional cells and tissues and deliver them to areas of clinical need.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

INDUSTRIAL IMPACT

BIOCONSORTIA SHOWCASES BREAKTHROUGH MICROBIAL PRODUCTS AND PIPELINE OF INNOVATION

BioConsortia, Inc. | September 05, 2022

news image

BioConsortia’s innovative microbial products and technical capabilities were on full display August 30th at its Davis, CA headquarters in an investor-focused Technology Showcase event. BioConsortia demonstrated rapid advancements in microbial product and pipeline developments for reducing nitrogen fertilizers, controlling soil pests and plant diseases for larger and better-quality crop yields, as well as protecting crops post-harvest to avoid food waste, while minimizing environmental impa...

Read More

CEDILLA THERAPEUTICS COMPLETES $82.6M SERIES B FINANCING

Cedilla Therapeutics | October 25, 2021

news image

Cedilla Therapeutics a biotechnology company bringing a new dimension to precision oncology, today announced that it has raised an additional $25 million in an expansion of its Series B financing, bringing the total amount raised to $82.6 million. The oversubscribed Series B expansion includes new investors RA Capital Management, Janus Henderson Investors, Woodline Partners LP and Logos Capital, along with participation from existing investor Third Rock Ventures.“We are grateful for the su...

Read More

OBSIDIAN THERAPEUTICS ANNOUNCES BRISTOL MYERS SQUIBB OPT-IN OF CYTODRIVE™ CELL THERAPY CANDIDATE

Obsidian Therapeutics | September 16, 2020

news image

Obsidian Therapeutics, Inc., a biotechnology company pioneering controllable cell and gene therapies, today announced that Bristol Myers Squibb (NYSE:BMY) has exercised its option to an exclusive worldwide license to a cell therapy candidate based on Obsidian's cytoDRiVE™ technology for the controlled expression of the immunomodulatory factor CD40L. This announcement marks the first opt-in decision by Bristol Myers Squibb since the companies announced their collaboration to develop nov...

Read More

FOOD MICROBIOLOGY TESTING MARKET 2020 IS BOOMING WORLDWIDE

Germany English News | April 08, 2020

news image

Food Microbiology Testing Market report provides an in-depth analysis of the overall market over a period from 2020-2026. The Food Microbiology Testing Market report also provides the market impact and new opportunities created due to the COVID19 catastrophe. The Food Microbiology Testing Market has been segmented based on different types and application. In order to provide a holistic view of the market current and future market, demand has been included in the report. The Food Microbiology Tes...

Read More
news image

INDUSTRIAL IMPACT

BIOCONSORTIA SHOWCASES BREAKTHROUGH MICROBIAL PRODUCTS AND PIPELINE OF INNOVATION

BioConsortia, Inc. | September 05, 2022

BioConsortia’s innovative microbial products and technical capabilities were on full display August 30th at its Davis, CA headquarters in an investor-focused Technology Showcase event. BioConsortia demonstrated rapid advancements in microbial product and pipeline developments for reducing nitrogen fertilizers, controlling soil pests and plant diseases for larger and better-quality crop yields, as well as protecting crops post-harvest to avoid food waste, while minimizing environmental impa...

Read More
news image

CEDILLA THERAPEUTICS COMPLETES $82.6M SERIES B FINANCING

Cedilla Therapeutics | October 25, 2021

Cedilla Therapeutics a biotechnology company bringing a new dimension to precision oncology, today announced that it has raised an additional $25 million in an expansion of its Series B financing, bringing the total amount raised to $82.6 million. The oversubscribed Series B expansion includes new investors RA Capital Management, Janus Henderson Investors, Woodline Partners LP and Logos Capital, along with participation from existing investor Third Rock Ventures.“We are grateful for the su...

Read More
news image

OBSIDIAN THERAPEUTICS ANNOUNCES BRISTOL MYERS SQUIBB OPT-IN OF CYTODRIVE™ CELL THERAPY CANDIDATE

Obsidian Therapeutics | September 16, 2020

Obsidian Therapeutics, Inc., a biotechnology company pioneering controllable cell and gene therapies, today announced that Bristol Myers Squibb (NYSE:BMY) has exercised its option to an exclusive worldwide license to a cell therapy candidate based on Obsidian's cytoDRiVE™ technology for the controlled expression of the immunomodulatory factor CD40L. This announcement marks the first opt-in decision by Bristol Myers Squibb since the companies announced their collaboration to develop nov...

Read More
news image

FOOD MICROBIOLOGY TESTING MARKET 2020 IS BOOMING WORLDWIDE

Germany English News | April 08, 2020

Food Microbiology Testing Market report provides an in-depth analysis of the overall market over a period from 2020-2026. The Food Microbiology Testing Market report also provides the market impact and new opportunities created due to the COVID19 catastrophe. The Food Microbiology Testing Market has been segmented based on different types and application. In order to provide a holistic view of the market current and future market, demand has been included in the report. The Food Microbiology Tes...

Read More